News & Events Year None202120202019201820172016201520142013201220112009 01/11/21 REGENXBIO to Present at the 39th Annual J.P. Morgan Healthcare Conference 01/08/21 REGENXBIO Announces Pricing Of Public Offering Of Common Stock 01/06/21 REGENXBIO Announces Proposed Public Offering Of Common Stock 01/05/21 REGENXBIO Announces Update on RGX-314 and Pivotal Program for the Treatment of Wet AMD and New Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
